16 financiaciones - 3.310.700€

datos disponibles desde el año 2018

2023

  1. Immune cell recruiters as novel bispecific constructs to maximize immune cell entrance into the tumors.

    euro 40.000,00

2022

  1. XPRIME, Exploring and exploiting crosspriming in cancer immunotherapy

    euro 299.639,00

  2. Evaluating the therapeutic potential of immunosuppressive paracrine cytokines in the tumor microenvironment of metastatic lesions

    euro 150.000,00

  3. Reposicionamiento de compuestos citotóxicos de organismos marinos para inmunoterapia intratumoral (RECYTSEA)

    euro 373.323,00

  4. Regulation and immunosuppressive effects of NETs extruded fr

    euro 181.250,00

  5. A spontaneous mouse model of antigenic hepatocellular carcin

    euro 402.316,00

2021

  1. Spatiotemporal dynamics of antitumor and pro-tumor immune responses in nascent and evolving colorectal cancer metastases to the liver

    euro 60.000,00

  2. ACTILNET. INTERLEUKIN-8 AND NEUTROPHIL EXTRACELULAR TRAPS AS ACTIONABLE HURDLES FOR CANCER IMMUNOTHERAPY

    euro 498.850,00

  3. Efectos inmunosupresores de las trampas extracelulares de neutrofilos en cáncer

    euro 192.390,00

  4. Evaluate the interplay between Neutrophils and NK Cells in t

    euro 143.000,00

  5. INTERLEUKIN-8 AND NEUTROPHIL EXTRACELLULAR TRAPS AS ACTIONABLE TARGET AND BIOMARKERS FOR CANCER IMMUNOTHERAPY

    euro 213.555,00

2020

  1. Interleukin-8 blockade and NETs

    euro 102.480,00

  2. MINCITH. Metabolic requirements for immune INfiltration in effective Cancer ImmunoTHerapy.

    euro 124.768,00

2019

  1. Attraction and formation of NETs in PMN and MDSC

    euro 31.429,00

2018

  1. Interleukin-8 in the tumor microenvironment

    euro 98.400,00

  2. ADMINISTRACION INTRATUMORAL Y DIANIZADA DE AGENTES DE INMUNOTERAPIA PARA EL TRATAMIENTO DEL CANCER

    euro 399.300,00